Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF March 25, 2016 | Archived Issues

FDA Warns About Zydelig

Pharmacy Focus

The U.S. Food and Drug Administration is alerting healthcare professionals about reports of an increased rate of adverse events, including deaths, in clinical trials with the cancer medicine Zydelig in combination with other cancer medicines.

» Read more


Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - March 2016 (PDF)  


Milestones

Morton W. Klein, MD, has died.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Updates Regarding Testing for Zika Virus Infection

The Los Angeles County Department of Public Health has updated its guidance for testing for Zika virus infection as indicated below:

  • Preapproval is no longer needed from the Public Health Department to submit serum specimens for Zika virus testing (there has been no change in indications for testing from prior communication).
  • Providers may submit specimens along with a completed Zika virus testing and report form (PDF). Specimens and completed forms will be shipped to the Public Health lab as per existing procedures for send-out tests.
  • Please note that certain situations still require phone call notification to the Los Angeles Acute Communicable Disease Control Program (ACDC) at 213-240-7941. These situations include:
  • Pregnant travelers with evidence of fetal microcephaly or calcifications
  • Infants with evidence of maternal Zika virus infection
  • Travelers with a Guillain-Barré diagnosis
  • A complete list of indications for phone call notification is found on the attached reporting form
  • Requests for testing specimens of amniotic fluid, placenta, cord blood or tissue from a fetus or newborn with microcephaly or intracranial calcifications should be made by phone to ACDC.

Additional information regarding Zika virus and testing can be found at: